基于生物降解的聚合物药物输送系统的研究进展,用于治疗膝关节骨关节炎
Jinchi Zhang1, Jinchao Zhang1, Hailong Li1
1Department of Medical, Qingdao Binhai University, Qingdao, China.
Frontiers in bioengineering and biotechnology
|April 25, 2025
概括
可生物降解的聚合物为膝关节骨关节炎 (KOA) 治疗提供了对手术的有希望的替代方案. 研究审查合成和天然聚合物用于药物输送,但需要进一步的临床试验来解决KOA管理的安全性和有效性问题.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 整形外科 整形外科 整形外科
背景情况:
- 膝关节骨关节炎 (KOA) 是一种进展性退行性关节疾病,导致疼痛,硬和行动能力受限.
- 目前对KOA的手术治疗有局限性,需要替代治疗策略.
- 可生物降解的聚合物材料为KOA管理中的药物输送提供了潜在的解决方案.
研究的目的:
- 审查用于膝关节骨关节炎治疗的可生物降解聚合物材料的研究进展.
- 探索合成和天然聚合物在KOA的药物输送系统中的应用.
- 确定基于聚合物材料的KOA疗法的挑战和未来方向.
主要方法:
- 关于可生物降解聚合物用于KOA处理的当前文献的综述.
- 合成聚合物的分析:聚乙烯 (PCL),聚乳酸 (PLA),聚乳糖酸 (PLGA),聚乙烯糖醇 (PEG).
- 对天然聚合物的评估:在药物输送系统中的原蛋白,丁硫酸盐和其他物质.
主要成果:
- 各种可生物降解的聚合物显示出在KOA治疗中药物输送的潜力.
- 聚合物材料可以用于控制药物释放,减少炎症和改善关节功能.
- 合成和天然聚合物在恢复膝关节的移动性和运动能力方面表现有前途.
结论:
- 可生物降解的聚合物越来越多地通过药物输送系统用于膝关节关节炎治疗.
- 进一步的临床试验对于解决可降解性,毒性,兼容性,耐用性和安全性的问题至关重要.
- 继续探索理想的聚合物材料对于推进KOA治疗干预至关重要.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
103
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
103
01:23Modified-Release Drug Delivery Systems: Classification
287
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
287
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
131
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
131
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
139
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
139
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127
01:11Oral Drug Delivery Systems: Delayed-Release Systems
179
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
179